Application of charge-coupled device technology for measurement of laser light and fluorescence distribution in tumors for photodynamic therapy.
Laser and fluorescence light distributions with applications for photodynamic therapy were measured in mouse tumors using a non-invasive electronic optical imaging system. The system consists of a liquid-nitrogen-cooled, charge-coupled-device (CCD) array camera under computer control with 576 x 384 detection elements having dimensions of 23 microns x 23 microns. The available dynamic range of the array is approx. 10(3), and the effective wavelength range is 400-1000 nm. An interstitially placed cylindrical diffusing optical fiber was used to provide tumor illumination. The light distribution pattern from the fiber was determined by immersing the cylindrical diffusing tip in a fluorescing solution and recording the emission image. Fluorescence imaging facilitates an accurate measurement of light intensity distribution while avoiding problems associated with the directional nature of other detection methods used with diffusing fibers. Radiation-induced fibrosarcoma tumors on C3H mice were grown to about 1 cm diameter for in vivo recording of light distribution from the tumor volume and for determination of effective light penetration distance at 18 wavelengths in the range 458-995 nm. Endogenous tumor fluorescence and Photofrin II fluorescence intensity were measured over the wavelength range 585-725 nm to investigate the possible application of CCD imaging technology for drug distribution measurements. Model experiments were begun to evaluate the relative importance of potential distortions of light distribution measurements using this approach.
Straight
R C
RC
VAMC/University of Utah Laser Institute, Department of Medicine, Salt Lake City 84132.
Benner
R E
RE
McClane
R W
RW
Go
P M
PM
Yoon
G
G
Dixon
J A
JA
D000818:Animals; D005354:Fibrosarcoma / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D053685:Laser Therapy; D051379:Mice; D008809:Mice, Inbred C3H; D009381:Neoplasms, Radiation-Induced / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D010778:Photochemotherapy; D012513:Sarcoma, Experimental / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D013050:Spectrometry, Fluorescence / Q000379:methods